Overcoming drug resistance with EAI-432, an allosteric EGFR inhibitor for non-small cell lung cancer
Credit score: Pixabay/CC0 Public Area Researchers at Dana-Farber Most cancers Institute have developed a promising new drug candidate, EAI-432, to ...